27 reports

  • MARKET CHALLENGES

There is a high demand for treatment that is characterized by effective and sustained pain relief, patient tolerability, low cost, and minimal side effects.

  • Type 2 Diabetes
  • Depomed, Inc.
  • Eli Lilly & Co.
  • Endo International plc
  • Pfizer Inc.

EpiCept NP-## is a topical analgesic cream containing two FDA-approved drugs, amitriptyline and ketamine, in development for the relief of pain from various peripheral neuropathies.

  • Therapy
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • ViroMed Co., Ltd.
  • PIPELINE BY DONG-A SOCIO HOLDINGS CO LTD, H1 2018

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Pharmaceutical
  • Type 2 Diabetes
  • United States
  • World
  • Product Initiative
  • PIPELINE BY F. HOFFMANN-LA ROCHE LTD, H2 2017

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Therapy
  • Type 2 Diabetes
  • United States
  • World
  • Product Initiative

In addition, pain relief was also observed in those patients that were not taking a single existing medicine for their PHN.

  • Pharmaceutical
  • Therapy
  • Type 2 Diabetes
  • World
  • Product Initiative
  • PIPELINE BY MERCK & CO INC, H1 2017

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Therapy
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • GlaxoSmithKline plc

EpiCept NP-## is a topical analgesic cream containing two FDA-approved drugs, amitriptyline and ketamine, in development for the relief of pain from various peripheral neuropathies.

  • Chronic Pain
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • ViroMed Co., Ltd.

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Type 2 Diabetes
  • Turkey
  • United States
  • World
  • Product Initiative

The company provides products to therapeutics areas which include pain relief, inflammation, CNS, cold & flu, oral care & sore throat, gynecology, disinfection.

  • Type 2 Diabetes
  • United States
  • World
  • Product Initiative
  • DiaMedica Inc.

Further, ## of the ## (##%) showed sustained pain relief over several weeks.

  • Chemotherapy
  • Neurological Disorder
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • XK-568B - DRUG PROFILE
  • CIBINETIDE - DRUG PROFILE

The primary outcomes are pain relief by VAS scores of most pain, least pain and average pain by questionnaire.

  • Neurological Disorder
  • Therapy
  • Type 2 Diabetes
  • United States
  • Product Initiative

In addition, pain relief was also observed in those patients that were not taking a single existing medicine for their PHN.

  • Pharmaceutical
  • Therapy
  • Type 2 Diabetes
  • World
  • Product Initiative

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Chronic Disease
  • Type 2 Diabetes
  • United States
  • Company
  • Product Initiative

The data demonstrated that CINGAL provided improved immediate and short term pain relief after injection as compared to HA alone, and enhanced relief from OA-related pain, stiffness and function through ## weeks as compared to saline.

  • Plastic Surgery
  • Type 2 Diabetes
  • United States
  • Company Financials
  • GlobalData's company
  • DIABETIC FOOT ULCERS - PIPELINE BY GENENTECH INC, H2 2017
  • DIABETIC FOOT ULCERS - PIPELINE BY GLAXOSMITHKLINE PLC, H2 2017

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Chronic Disease
  • Therapy
  • Type 2 Diabetes
  • Wound Care
  • Product Initiative
  • 5. All the trials included are unique trials.

Aflibercept in Patients with Diabetic Macular Edema Evaluation of Inflammation and Pain Post Injection of Ranibizumab Vs.

  • Clinical Trial
  • Endocrine Disease
  • Pharmaceutical
  • Type 2 Diabetes
  • World
  • DIABETIC NEPHROPATHY - PIPELINE BY PHILOGENE INC, H2 2017
  • DIABETIC NEPHROPATHY - PIPELINE BY PHYTOHEALTH CORP, H2 2017

The primary outcomes are pain relief by VAS scores of most pain, least pain and average pain by questionnaire.

  • Pharmaceutical
  • Type 2 Diabetes
  • United States
  • World
  • Product Initiative

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Ophthalmology
  • Type 2 Diabetes
  • Company
  • Product Initiative
  • Allergan plc
  • Clinical Trial profile. 141 Trial Title

Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2016" provides an overview of Peripheral Neuropathy (Sensory Neuropathy) clinical trials scenario. This report provides...

  • Neurological Disorder
  • Neurology
  • Type 2 Diabetes
  • World
  • Product Initiative
  • DIABETIC FOOT ULCERS - PIPELINE BY HUMAN STEM CELLS INSTITUTE, H1 2017
  • DIABETIC FOOT ULCERS - PIPELINE BY GLAXOSMITHKLINE PLC, H1 2017

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Type 2 Diabetes
  • Wound Care
  • United States
  • World
  • Product Initiative
  • CIBINETIDE - DRUG PROFILE

The primary outcomes are pain relief by VAS scores of most pain, least pain and average pain by questionnaire.

  • Neurological Disorder
  • Neurology
  • Type 2 Diabetes
  • United States
  • Company Operations

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Type 2 Diabetes
  • United States
  • World
  • Company
  • Product Initiative
  • DIABETIC NEPHROPATHY - PIPELINE BY PHILOGENE INC, H1 2018
  • DIABETIC NEPHROPATHY - PIPELINE BY PHYTOHEALTH CORP, H1 2018

The primary outcomes are pain relief by VAS scores of most pain, least pain and average pain by questionnaire.

  • Pharmaceutical
  • Therapy
  • Type 2 Diabetes
  • United States
  • Product Initiative

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Autoimmune Disease
  • Therapy
  • Type 2 Diabetes
  • United States
  • Product Initiative

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Pharmaceutical
  • Type 2 Diabetes
  • United States
  • Company
  • Product Initiative

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Pharmaceutical
  • Type 2 Diabetes
  • United States
  • Company
  • Product Initiative

The secondary outcome measures of the study were tumor response assessed via CT scan using RECIST and effects on pain relief using a patient self-assessment pain scale.

  • Cancer
  • Therapy
  • Type 2 Diabetes
  • United States
  • Amgen Inc.